Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations

Contraception

Volumn 71, Issue 4, 2005, Pages 304-305

  Mishell Jr , Daniel R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; GONADOTROPIN; LUTEINIZING HORMONE; MESTRANOL; NORETYNODREL; ORAL CONTRACEPTIVE AGENT; STEROID;

BLEEDING; BLOATING; BREAST TENDERNESS; CHLOASMA; CONFIDENCE INTERVAL; CONTRACEPTION; DRUG ACTIVITY; DRUG FORMULARY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENCY; DRUG SYNTHESIS; EDEMA; FLUID RETENTION; FREQUENCY ANALYSIS; GROWTH INHIBITION; HEADACHE; HORMONAL REGULATION; HUMAN; INCIDENCE; LOW DRUG DOSE; MOOD DISORDER; NAUSEA; NOTE; OVULATION; PELVIS PAIN SYNDROME; PREGNANCY; PREMATURITY; RISK ASSESSMENT; SIDE EFFECT; THROMBOEMBOLISM; UNITED STATES;

EID: 15744363767     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.12.012     Document Type: Editorial

References (11)

1. P.F. Brenner, D.R. Mishell Jr., F.Z. Stanczyk, and U. Goebelsmann Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel Am J Obstet Gynecol 128 1977 133 140
2. D.R. Mishell Jr. Family planning M.A. Stenchever W. Droegemueller A.L. Herbst D.R. Mishell Jr. Comprehensive gynecology 4th ed. 2001 Mosby St Louis (MO) 295 338
3. B.B. Gertsman, J.M. Piper, and D.K. Tomita Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease Am J Epidemiol 133 1991 32 37
4. T.B. Appel, A.A. Kambi, and C. Bidsall A comparison of a new graduated estrogen formulation with three constant-dose oral contraceptives Contraception 35 1987 523 532
5. M.J. Rosenberg, and M.S. Waugh Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons Am J Obstet Gynecol 179 1998 544 582
6. A.M. van Heusden, and B.C.J.M. Fauser Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives Contraception 59 1999 237 243
7. A.R. Baerwald, O.a. Olatunbosun, and R.A. Pierson Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use Contraception 70 2004 371 377
8. M.D. Creinin, J.S. Lippman, B.E. Eder, A.J. Godwin, and W. Olson The effect of extending the pill-free interval on follicular activity: Triphasic norgestimate/35 μg ethinyl estradiol versus monophasic levonorgestrel/20 μg ethinyl estradiol Contraception 66 2002 147 152
9. J. Trussell Contraceptive failure in the United States Contraception 70 2004 89 96
10. J. Spona, M. Eistein, and W. Feichtinger Shorter pill-free interval in combined oral contraceptives decreases follicular development Contraception 54 1996 71 77
11. P.J. Sulak, R.D. Scow, C. Preece, M.W. Riggs, and T.J. Kuehl Hormone withdrawal symptoms in oral contraceptive users Obstet Gynecol 95 2000 261 265